STOCK TITAN

Infleqtion, Inc. 424B Filings

INFQ NYSE

Every 424B that Infleqtion, Inc. (INFQ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow INFQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INFQ filings page.

Rhea-AI Summary

Infleqtion, Inc. (INFQ) filed a prospectus supplement to its Form S-1 to update the list of selling securityholders for an existing mixed primary and resale registration. The registration covers issuance of up to 10,425,000 shares of common stock upon exercise of outstanding public and private warrants, from which Infleqtion would receive cash proceeds upon any such exercises.

The registration also covers the potential resale by selling securityholders of up to 121,829,432 shares of common stock and up to 75,000 Private Warrants, from which Infleqtion will receive no proceeds. This supplement reflects an in-kind distribution of 350,115 shares of common stock from Maverick Capital Advisors, LP and updates the “Selling Securityholders” table to show Ainslie Foundation as holder of those registered resale shares.

Rhea-AI Summary

Infleqtion, Inc. filed a prospectus supplement to its April 2026 S‑1 to incorporate its unaudited Form 10‑Q for the quarter ended June 30, 2026. Infleqtion develops and commercializes full‑stack quantum technology, including sensing, computing and software, and completed a SPAC Business Combination with Churchill Capital Corp X in February 2026.

For the three months ended June 30, 2026, Infleqtion reported revenue of $13.5 million and a net loss of $24.7 million. For the first six months of 2026, revenue was $23.4 million with a net loss of $54.4 million. Government customers provided 89% of year‑to‑date revenue, with one customer accounting for 74%. Following the Business Combination and PIPE financing, cash, cash equivalents and available‑for‑sale securities totaled over $581 million, and total assets were $641.5 million as of June 30, 2026. Common shares outstanding increased to 224.7 million at quarter‑end and 225.4 million by August 14, 2026.

Rhea-AI Summary

Infleqtion is registering for resale up to 121,829,432 shares of Common Stock and up to 75,000 Private Warrants held by selling securityholders. Separately, it may issue up to 10,425,000 shares of Common Stock upon exercise of outstanding Public and Private Warrants, from which it would receive cash proceeds.

The registration covers shares issued in the Business Combination, including 12,654,760 PIPE Shares, 10,350,000 Founder Shares, 300,000 CCX Private Placement Shares and 98,449,672 shares held by Legacy Infleqtion Holders, plus 75,000 shares underlying Private Warrants. A prospectus supplement updates the selling securityholder table to reflect an in-kind distribution of 23,251,796 shares of Common Stock by entities affiliated with Global Frontier to certain limited partners as of July 10, 2026.

Infleqtion will not receive proceeds from any resale of shares or warrants by selling securityholders. It is an emerging growth company, and its Common Stock and Public Warrants trade on NYSE under “INFQ” and “INFQ WS,” last at $10.45 per share and $5.35 per warrant on July 14, 2026.

Rhea-AI Summary

INFQ is registering securities for resale: the prospectus supplement registers up to 10,425,000 shares of Common Stock issuable upon exercise of Warrants, up to 121,829,432 shares of Common Stock for resale by selling securityholders, and up to 75,000 Private Warrants. The registration is being filed pursuant to the Selling Securityholders' registration rights and updates the list of selling holders to reflect an in‑kind distribution of 3,825,935 shares by entities affiliated with Maverick Capital as of June 2, 2026. The company will receive cash proceeds from any exercise of Warrants but will not receive proceeds from secondary sales by the Selling Securityholders. The supplement also states last reported NYSE prices on June 4, 2026: $16.95 per share for Common Stock and $8.88 per Public Warrant.

Rhea-AI Summary

Infleqtion, Inc. filed a prospectus supplement dated May 15, 2026 that attaches its Quarterly Report on Form 10‑Q for the quarter ended March 31, 2026.

The 10‑Q shows cash and cash equivalents of $84,674 (in thousands) and available‑for‑sale securities with a fair value of $483,983 (in thousands) as of March 31, 2026. The Company reported a net loss of $(30,263) (in thousands) for the three months ended March 31, 2026. As of March 31, 2026 there were 216,471,927 shares of Common Stock issued and outstanding; the filing also states 218,196,891 shares issued and outstanding as of May 12, 2026.

Rhea-AI Summary

Infleqtion, Inc. filed a prospectus supplement dated May 14, 2026 that attaches its Form 8-K and updates the S-1 prospectus. The supplement discloses the Board appointment of Nicholas Johnson as a Class III director with a term expiring at the 2029 annual meeting.

The filing also reiterates that Advisory Agreement terms disclosed earlier remain in effect: the Advisor will be paid $250,000 per quarter and is entitled to 5% of underwriting fees and 3% of gross proceeds on strategic investments if retained. The supplement lists last reported NYSE prices as $13.29 per share for Common Stock and $6.61 per Public Warrant (as of May 13, 2026).